BP004480: Human CXCL16 Protein with the C-hFc Tag
Source: The recombinant Human CXCL16 Protein, (amino acids Asn30-Thr205) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005015: Human ICAM-1/CD54 Protein with the C-His Tag
Source: The recombinant Human ICAM-1/CD54 Protein, (amino acids Gln28-Glu480) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human ICAM-1 protein with the C-His tag at 0.5 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Anti-ICAM-1 Antibody protein with the C-hFc tag with the EC50 of 5.6 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.APIM050065: TAK-931 (SIMUROSERTIB)
CAS No.: 1330782-76-7.
Purity: >99.7% chem and optical purity (by achiral and chiral HPLCs).
QC: Achiral and Chiral HPLCs, 1H-NMR, and Quantitative Elemental Analysis Report.
Solubility: Refer to Certificate of Analysis.BP001722-CE45: Recombinant Human Parafibromin Protein
Source: E. coli-derived.
Purity: > 95% by reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP002745-PKA-269: Recombinant Human Cyclin-Dependent Kinase 2 Interacting Protein (CINP)
Source: E. coli-derived.
Purity: > 95.0% as determined by SDS-PAGE.APIM050244: TAK-931 (SIMUROSERTIB)
CAS No.: 1330782-76-7.
Purity: >99.7% chem and optical purity (by achiral and chiral HPLCs).
QC: Achiral and Chiral HPLCs, 1H-NMR, and Quantitative Elemental Analysis Report.
Solubility: Refer to Certificate of Analysis.C068P: Isatuximab Biosimilar, CD38 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade isatuximab biosimilar specifically binds to the human CD38 proteins.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by isatuximab.